Vivek Dhruva is a Cardiology physician. OpenAlex indexes 13 publications with 258 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
520 Upper Chesapeake Dr
Suite 201
Bel Air, MD 210144339
Telephone
443-643-3800Registry record last updated 24 Jun 2010.
Industry payments
15 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Kestra Medical Technology Services, Inc.Program year202510 payments
- ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Program year20251 payment
- HEARTFLOW, INC.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
84.2%Beta blocker22%Metoprolol Succinate50%Metoprolol Tartrate31%Carvedilol12%Labetalol Hcl3%Atenolol2%Sotalol1%Nebivolol Hcl1%Part D<11 patientsStatin15.3%Atorvastatin Calcium45%Rosuvastatin Calcium42%Pravastatin Sodium8%Simvastatin5%Part D≥164 patients+ 21 more classes in this area
Blood & clotting
14.4%Factor Xa inhibitor11.1%Eliquis73%Xarelto27%Part D≥162 patientsP2Y12 inhibitor3.1%Clopidogrel93%Brilinta7%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
1.4%Potassium supplement0.6%Potassium Chloride100%Part D≥16 patientsSGLT2 inhibitor0.6%Jardiance100%Part D≥13 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- INITIAL RESULTS OF A NEW INDEPENDENT DIAGNOSTIC TESTING FACILITY DESIGN FOR PATIENT-GENERATED SMARTPHONE-ECG ARRHYTHMIA DETECTION. THE ALIVECOR-IDTF PROGRAM.
Journal of the American College of Cardiology
2022 - The STAT-MI (ST-Segment Analysis Using Wireless Technology in Acute Myocardial Infarction) Trial Improves Outcomes
JACC: Cardiovascular Interventions
2011 - Abstract 4511: Wireless Technology Improves Outcomes and Eliminates Gender Bias in Acute Myocardial Infarction
Circulation
2009
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”